Viewing nowHyniz Olmesartan Medoxomil Tablets
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hyunus Meditech Co., Ltd.

MFDS item code 201503641 · Approved 2015.06.08 · Insurance code 670400970
Improvement of essential hypertension
This medication is used in the treatment of essential hypertension to help stabilize blood pressure. It helps control blood pressure by expanding blood vessels or reducing the burden on the heart. By continuing to take this medication, it stabilizes blood pressure and contributes to the prevention of cardiovascular complications. Appropriate dosage adjustments may be necessary based on the patient's condition, and it should be used under the guidance of a physician. Through the treatment of essential hypertension, it reduces the risk of serious conditions such as heart attacks and strokes.
The recommended initial dose is 10 mg once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 20 mg once daily. It can be increased up to a maximum of 40 mg daily. The blood pressure-lowering effect is observed within 2 weeks after starting treatment, with maximum effect occurring around 8 weeks. It can be administered in combination with thiazide diuretics such as hydrochlorothiazide.
The safety and efficacy in children have not been established.
This medication can cause severe harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to this drug or any of its components, pregnant or lactating women, patients on renal dialysis, patients with severe liver dysfunction, patients with biliary obstruction, and those with genetic issues such as lactose intolerance should not take this medication. In patients with reduced blood volume or sodium, hypotension may occur, so conditions should be checked before taking the drug, and hypotension symptoms should be closely monitored during use. Patients with impaired kidney function or kidney transplant recipients should regularly check potassium and creatinine levels through blood tests, and it is not recommended for patients with severe renal impairment. Due to the risk of hyperkalemia, particularly in patients with heart failure or renal impairment, serum potassium levels should be monitored closely. This drug has a blood pressure-lowering effect, so dizziness may occur; it is advisable to avoid dangerous activities such as operating machinery or driving while taking it. During the use of this medication, liver function and blood pressure should be regularly checked, and if symptoms such as chronic diarrhea or abdominal pain occur, medical consultation should be sought immediately. Caution is needed when taken with other antihypertensives, potassium-sparing diuretics, or potassium supplements, as potassium levels may increase. When taken with lithium, blood lithium levels may increase, potentially leading to toxicity, and such co-administration is not recommended. Co-administration with non-steroidal anti-inflammatory drugs may worsen renal function, so it is necessary to maintain adequate hydration and monitor renal function. If a pregnant woman takes this medication, there is a risk of decreased renal function in the fetus, oligohydramnios, and neonatal death, so it should not be taken during pregnancy, and it is essential to consult a physician if pregnancy is planned or confirmed. Lactating women should be aware that this medication may be passed into breast milk and could cause adverse reactions in infants, so it is advisable to either discontinue breastfeeding or stop the medication. The safety and efficacy for children have not been established, so it is not advised for pediatric use. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention should be sought for appropriate treatment. There is no evidence of carcinogenic or genotoxicity after long-term use of this medication, but if abnormal symptoms occur during use, consult a physician immediately.
Urticaria, angioedema, anaphylactic reaction, acute renal failure, hyperkalemia, urticaria, liver function abnormalities (increased liver enzymes or bilirubin), severe edema, increased blood pressure, asthma attack, severe allergic reactions
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air or moisture and kept at room temperature between 1 to 25 degrees Celsius. Proper storage can maintain the efficacy of the medication and prevent degradation.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Hyunus Meditech Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.